{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:09:33Z","timestamp":1791252573456,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.parkreldis.2015.09.034","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T18:24:39Z","timestamp":1442859879000},"page":"S144-S148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"special_numbering":"S1","title":["Cognitive impairment in Parkinson's disease and dementia with Lewy bodies"],"prefix":"10.1016","volume":"22","author":[{"given":"Dag","family":"Aarsland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.parkreldis.2015.09.034_bib1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","article-title":"DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers","volume":"68","author":"Lippa","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2015.09.034_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"issue":"Pt 7","key":"10.1016\/j.parkreldis.2015.09.034_bib3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson's disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.parkreldis.2015.09.034_bib4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2015.09.034_bib5","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2015.09.034_bib6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/jnnp.2009.189142","article-title":"15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort","volume":"81","author":"Perez","year":"2010","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2015.09.034_bib7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.parkreldis.2015.09.034_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"19","key":"10.1016\/j.parkreldis.2015.09.034_bib9","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","article-title":"GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology","volume":"79","author":"Tsuang","year":"2012","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.parkreldis.2015.09.034_bib10","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"Pt 10","key":"10.1016\/j.parkreldis.2015.09.034_bib11","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study","volume":"137","author":"Nombela","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.09.034_bib12","article-title":"GBA variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease","author":"Mata","year":"2015","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2015.09.034_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2015.09.034_bib14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2015.09.034_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jnp.12015","article-title":"Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease","volume":"7","author":"Christopher","year":"2013","journal-title":"J.\u00a0Neuropsychol."},{"issue":"3","key":"10.1016\/j.parkreldis.2015.09.034_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-2012-121603","article-title":"Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment","volume":"33","author":"Selnes","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.parkreldis.2015.09.034_bib17","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/hbm.22822","article-title":"Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease","volume":"36","author":"Pereira","year":"2015","journal-title":"Hum. Brain Mapp."},{"issue":"16 Pt 2","key":"10.1016\/j.parkreldis.2015.09.034_bib18","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/01.wnl.0000304050.05332.9c","article-title":"Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease","volume":"70","author":"Huang","year":"2008","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2015.09.034_bib19","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.26191","article-title":"Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review","volume":"30","author":"Petrou","year":"2015","journal-title":"Mov. Disord."},{"issue":"Pt 3","key":"10.1016\/j.parkreldis.2015.09.034_bib20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/brain\/awm322","article-title":"EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up","volume":"131","author":"Bonanni","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.parkreldis.2015.09.034_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neurobiolaging.2014.07.009","article-title":"Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies","volume":"36","author":"Bonanni","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.parkreldis.2015.09.034_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2013.03.009","article-title":"Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study","volume":"19","author":"Compta","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"Pt 6","key":"10.1016\/j.parkreldis.2015.09.034_bib23","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awq059","article-title":"Relationships between age and late progression of Parkinson's disease: a clinico-pathological study","volume":"133","author":"Kempster","year":"2010","journal-title":"Brain"},{"issue":"5\u20138","key":"10.1016\/j.parkreldis.2015.09.034_bib24","first-page":"53","article-title":"A\u00a0systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer's disease","volume":"6","author":"Breitve","year":"2014","journal-title":"Alzheimers Res. Ther."},{"issue":"8","key":"10.1016\/j.parkreldis.2015.09.034_bib25","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/mds.25377","article-title":"Nonpharmacological enhancement of cognitive function in Parkinson's disease: a systematic review","volume":"28","author":"Hindle","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.09.034_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26291","article-title":"Exercise improves cognition in Parkinson's disease: the PRET-PD randomized, clinical trial","author":"David","year":"2015","journal-title":"Mov. Disord."},{"issue":"23","key":"10.1016\/j.parkreldis.2015.09.034_bib27","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1212\/WNL.0000000000001043","article-title":"Improving functional disability and cognition in Parkinson disease: randomized controlled trial","volume":"83","author":"Pena","year":"2014","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.parkreldis.2015.09.034_bib28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1176\/appi.ajp.2015.14121582","article-title":"Pharmacological management of Lewy body dementia: a systematic review and meta-analysis","volume":"172","author":"Stinton","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.parkreldis.2015.09.034_bib29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.26236","article-title":"Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study","volume":"30","author":"Mamikonyan","year":"2015","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2015.09.034_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015004253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015004253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T16:53:05Z","timestamp":1567183985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802015004253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":30,"alternative-id":["S1353802015004253"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.034","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive impairment in Parkinson's disease and dementia with Lewy bodies","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}